3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
20
INDUSTRY
2
OTHER_GOV
1
NETWORK
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Pancreatic adenoma
2
Pancreatic Neoplasms
2
Pancreatic Cyst
2
Lymphadenopathy
2
Cysts
2
Arachnodactyly
2
Adenoma, Islet Cell
2
Interventions
Gemcitabine
205
130-nm albumin-bound paclitaxel
84
Albumin-Bound Paclitaxel
57
pembrolizumab
43
Fluorouracil
41
Leucovorin
34
Oxaliplatin
33
Capecitabine
25
Nivolumab
22
Irinotecan
19
Bevacizumab
17
Paclitaxel
16
Cyclophosphamide
15
Cetuximab
15
Taxes
13
Erlotinib Hydrochloride
13
Drug Therapy
13
Carboplatin
12
irinotecan sucrosofate
11
Injections
10
Cisplatin
9
fludarabine
8
ALT-803
8
spartalizumab
7
olaparib
7
avelumab
7
Pemetrexed
7
Docetaxel
7
ruxolitinib
6
TH 302
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Pancreatic Neoplasms
×
Endoscopic Ultrasound-Guided Fine Needle Aspiration
×
Clear all
NCT01563133
2017-08-29
CONTACT
Mauna Kea Technologies
Phase NA
Unknown
330 enrolled
NCT01770405
2017-08-29
US-nCLE
Mauna Kea Technologies
Completed
40 enrolled